Trim 30-40% of IBM immediately; re-engage above $247 on volume confirmation
Execute 30-40% trim immediately at market to avoid the -1.0% alpha destruction observed on the 9/16 modest 10-15% trim. The fundamental deterioration (H1 revenue -2.5% YoY to $33.08B, EPS -15% YoY to $3.55) and aggressive debt accumulation ($41B to $54.8B net debt in 18 months, HashiCorp-funded at 13-15x revenue) support meaningful sizing. Re-engage only on confirmed breakout at $247 with volume >6M — not the $256.91 200 SMA which is regime-change confirmation, not an actionable trigger. Maintain residual for income given 2.85% yield; hedge with TLT puts against rate-sensitive leveraged balance sheet. Price target of $220 represents 21-point risk from $235 trader entry on 12-18 point target — poor risk/reward without the 30-40% trim.
| Position | Action |
|---|---|
| Immediate action required | Trim 30-40% of IBM exposure at market |
| Income mandates apply | Maintain full position to capture 2.85% dividend yield |
IBM is a defensible compounder mispriced by the market, which conflates tactical noise (technical weakness, hawkish Fed headwinds) with fundamental deterioration, while ignoring structural tailwinds: margin expansion to 18.5% operating margin, $11.5B annual FCF, $1B federal quantum foundry award, and HashiCorp's strategic platform integration for the $1T hybrid cloud market.
| Indicator | Value | Signal |
|---|---|---|
| Close | 237.75 | neutral |
| 10 EMA | 239.41 | bearish |
| 50 SMA | 232.78 | bearish |
| 200 SMA | 256.91 | bearish |
| RSI (14) | 50.50 | neutral |
| Bollinger Upper Band | 247.04 | bearish |
| Bollinger Middle Band | 236.37 | neutral |
| Bollinger Lower Band | 225.70 | bullish |
| MACD | 1.73 | neutral |
| MACD Signal | 0.94 | neutral |
| MACD Histogram | +0.79 |
This report is AI-generated for informational and educational purposes only and is not investment advice or a recommendation to buy or sell any security. Full disclaimer.
When: Close above $256.91 200 SMA
Then: Not used as entry — represents late confirmation, not actionable trigger
IBM's margin expansion is structural and substantial, not a value trap
EV: +15.6% to +26.2% ($275–$300 on $237.75 base) · concedes: Q2 2026 software deal slippage warrants monitoring — if deals were timing delays (not cancellations), current price already reflects the risk; if truly lost, downside exists; Quantum foundry commercial demand is undisclosed — revenue conversion is 3-5 year build-out, not near-term catalyst; HashiCorp integration execution risk is real at $10.5B scale; Hawkish Fed (95% probability of no cuts in 2026) creates headwinds for multiple expansion in tech sector; PEG ratio of 2.25 is elevated — though PEG is unreliable for low-growth, high-cash-flow businesses; Post-rally blow-off top at $330 contaminates the 200 SMA level, making technical analysis less reliable
IBM is a "Sell/Short" because it is priced for perfection but delivering mediocrity, with asymmetric downside risk of 26% to $175 versus upside of only 12% to $265, driven by declining FCF, rising debt, unresolved Q2 software slippage, and quantum optionality that remains unvalidated and undisbursed.
EV: -26% to $175 (bear case); -9% to $215 (base case); +12% to $265 (bull case) · concedes: FCF numbers are real; Margin expansion from FY22 to FY25 is real (500 bps); CHIPS Act $1B award is real; IBM has quality assets; If IBM becomes the foundry for the entire quantum industry, that is a defensible moat; Industrial infrastructure does take 3-5 years to convert to revenue
→ vs conservative: Defensive dividend thesis is value destruction disguised as safety — a 2.85% yield doesn't offset a 26% principal decline; the foundation (fundamentals) is cracking with revenue and EPS declining
→ vs conservative: 100+ year track record is irrelevant when the business is deteriorating — net debt up $13.8B in 18 months and FCF declining while Fed is hiking rates creates a slow-motion debt spiral
→ vs neutral: HOLD with tactical short bias is paralysis dressed as prudence — the technical setup (RSI bearish divergence, MACD histogram shrinking, momentum exhaustion) has already confirmed the downtrend
→ vs neutral: Waiting for confirmation is too late when price is already 28% below the 200-day and the marginal catalyst (CHIPS Act) already failed to move shares higher
| bearish |
| ATR (14) | 7.47 | neutral |
Support: — | Resistance: 247.04 · 256.91
IBM exhibits a confirmed long-term downtrend with price 7.5% below the 200 SMA at $256.91, which acts as heavy overhead resistance. Short-term momentum is weakening: the 10 EMA at $239.41 has flipped overhead resistance after price rejected the $249 zone on September 14-15. A Bollinger Band squeeze is in effect with tight bounds between $225.70 and $247.04, setting up a potential directional breakout. RSI neutral at 50.50 following bearish divergence, and MACD histogram is shrinking, suggesting the bounce from July lows is losing thrust. ATR has compressed to 7.47 from a July peak of 15.24, indicating elevated but normalizing volatility.
Market Cap
$223.99B
Share Price
~$237.8
P/E (TTM)
21.11x
Forward P/E
18.06x
PEG Ratio
2.25
P/B
6.50x
Dividend Yield
2.85%
Beta
0.708
52-Week Range
$199.19 – $332.46
50-DMA
$234.79
200-DMA
$260.35
Revenue (TTM)
$69.09B
Net Income (TTM)
$10.71B
EPS (TTM)
$11.26
Forward EPS
$13.16
Free Cash Flow (TTM)
$12.05B
Profit Margin
15.52%
Operating Margin
16.55%
ROE
34.46%
ROA
5.30%
Revenue FY2025
$67,536M
Gross Profit FY2025
$39,297M
Operating Income FY2025
$12,492M
Net Income FY2025
$10,593M
Diluted EPS FY2025
$11.17
EBITDA FY2025
$17,284M
Revenue Q2 2026
$17,162M
EPS Q2 2026
$2.27
Total Assets
$152,099M
Goodwill + Intangibles
$88,553M
Total Debt
$65,272M
Net Debt
$54,815M
Debt/Equity
1.89x
Net Debt/EBITDA
~3.3x
Current Ratio
0.79
Operating Cash Flow FY2025
$13,193M
Free Cash Flow FY2025
$11,455M
FCF/Share
~$12
FCF Yield (TTM)
5.4%
Dividends Paid FY2025
$6,255M
Buybacks FY2025
$1,018M
Acquisitions FY2025
$8,295M
ROIC (est.)
~13%
Tangible Book Value
-$54.1B
Pension Liability
$12.0B
Gross Margin Expansion (4Y)
~420 bps
Operating Margin Expansion (4Y)
~500 bps
Revenue 5Y CAGR
~3.2%
R&D Spend FY2025
$8.32B
Strengths
Concerns
IBM is a defensive enterprise tech franchise executing a credible transformation toward AI and hybrid cloud, with FY2025 revenue up 7.6% YoY and operating margins expanding 500 bps over four years to 18.5%. The company generates robust FCF ($11.46B in FY2025) that comfortably supports its 2.85% dividend yield and 100+ year dividend track record, though the stock trades below its 200-day moving average amid skepticism about AI monetization pace. Near-term headwinds include H1 2026 revenue decline (~2.5% YoY), elevated net debt ($54.8B post-HashiCorp), and a PEG ratio of 2.25 that prices in aggressive growth recovery, making this best suited for income-oriented defensive portfolios rather than aggressive growth strategies.
Macro: Hawkish Fed regime with 95% probability of no rate cuts in 2026, creating a headwind for long-duration quantum/AI optionality while supporting enterprise IT-services and consulting revenue base. Soft-landing consensus holds with US recession risk at 10% (up 1.0pp in a week), UK 10%, Japan 6%.